ArticleTranslational cancer research2026
A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.
Yanyan Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.